Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT

Autor: Adam Devall, Justin Chu, Leanne Beeson, Pollyanna Hardy, Versha Cheed, Yongzhong Sun, Tracy Roberts, Chidubem Okeke Ogwulu, Eleanor Williams, Laura Jones, Jenny La Fontaine Papadopoulos, Ruth Bender-Atik, Jane Brewin, Kim Hinshaw, Meenakshi Choudhary, Amna Ahmed, Joel Naftalin, Natalie Nunes, Abigail Oliver, Feras Izzat, Kalsang Bhatia, Ismail Hassan, Yadava Jeve, Judith Hamilton, Shilpa Deb, Cecilia Bottomley, Jackie Ross, Linda Watkins, Martyn Underwood, Ying Cheong, Chitra Kumar, Pratima Gupta, Rachel Small, Stewart Pringle, Frances Hodge, Anupama Shahid, Ioannis Gallos, Andrew Horne, Siobhan Quenby, Arri Coomarasamy

Publikováno v: Health Technology Assessment, Vol 25, Iss 68 (2021)

Trial design: A randomised, parallel-group, double-blind, placebo-controlled multicentre study with health economic and nested qualitative studies to determine if mifepristone (Mifegyne®, Exelgyn, Paris, France) plus misoprostol is superior to misop

Externí odkaz: https://doaj.org/article/a7b7fdf1ce9c4e479354a4c24a6277e0

Comparison of manual vacuum aspiration to traditional methods of managing early pregnancy miscarriage: How does MVA compare to alternative methods of miscarriage management?

Autor: Oscar MacCormac, Alexandra Edwards, Murray Forsyth, Fanny Ti, Shilpa Deb

Publikováno v: Cogent Medicine, Vol 5, Iss 1 (2018)

A prospective study of 125 patients diagnosed with first trimester miscarriage was carried out in order to compare management outcomes and patient satisfaction. Miscarriage managed medically and surgically was compared. A comfort score between 1 and

Externí odkaz: https://doaj.org/article/e1f58dd8d29540d1b465ff3a989b95e0

Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT

Autor: Ismail Hassan, Pratima Gupta, Versha Cheed, Jane Brewin, A. Shahid, Tracy E Roberts, Cecilia Bottomley, Justin Chu, Jackie Ross, A. Ahmed, Abigail Oliver, J. Naftalin, Chidubem Okeke Ogwulu, Yadava B. Jeve, Pollyanna Hardy, Rachel Small, Andrew W Horne, Shilpa Deb, Martyn Underwood, Adam J. Devall, Kim Hinshaw, Ying Cheong, Laura Jones, Eleanor Williams, Jenny H La Fontaine Papadopoulos, Leanne Beeson, Linda Watkins, Natalie Nunes, Judith Hamilton, Siobhan Quenby, Yongzhong Sun, Frances Hodge, Meenakshi Choudhary, Chitra S Kumar, Arri Coomarasamy, Ioannis D. Gallos, Feras Izzat, Stewart Pringle, Ruth Bender-Atik, Kalsang Bhatia

Publikováno v: Health Technology Assessment, Vol 25, Iss 68 (2021)

Trial design A randomised, parallel-group, double-blind, placebo-controlled multicentre study with health economic and nested qualitative studies to determine if mifepristone (Mifegyne®, Exelgyn, Paris, France) plus misoprostol is superior to misopr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1526b20a49ed6d807b806a73416a08d4
https://ora.ox.ac.uk/objects/uuid:13a1d72d-07dc-4b3a-b8ab-f19f33b8f9f4

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso):a randomised, double-blind, placebo-controlled trial

Autor: C B Okeke Ogwulu, Laura Jones, Leanne Beeson, Shilpa Deb, Kalsang Bhatia, Jackie Ross, Chitra S Kumar, Jenny H La Fontaine Papadopoulos, Abigail Oliver, Justin Chu, Meenakshi Choudhary, Natalie Nunes, Ying Cheong, Judith Hamilton, J. Naftalin, Pratima Gupta, Yongzhong Sun, Rachel Small, Andrew W Horne, Cecilia Bottomley, Adam J. Devall, Eleanor Williams, Linda Watkins, Arri Coomarasamy, Tracy E Roberts, Frances Hodge, A. Ahmed, Siobhan Quenby, A. Shahid, Ismail Hassan, Ioannis D. Gallos, Pollyanna Hardy, Yadava B. Jeve, Versha Cheed, Jane Brewin, Ruth Bender-Atik, Martyn Underwood, Kim Hinshaw, Stewart Pringle, Feras Izzat

Publikováno v: Chu, J J, Devall, A J, Beeson, L E, Hardy, P, Cheed, V, Sun, Y, Roberts, T E, Ogwulu, C O, Williams, E, Jones, L L, La Fontaine Papadopoulos, J H, Bender-Atik, R, Brewin, J, Hinshaw, K, Choudhary, M, Ahmed, A, Naftalin, J, Nunes, N, Oliver, A, Izzat, F, Bhatia, K, Hassan, I, Jeve, Y, Hamilton, J, Deb, S, Bottomley, C, Ross, J, Watkins, L, Underwood, M, Cheong, Y, Kumar, C S, Gupta, P, Small, R, Pringle, S, Hodge, F, Shahid, A, Gallos, I D, Horne, A W, Quenby, S & Coomarasamy, A 2020, ' Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso) : a randomised, double-blind, placebo-controlled trial ', The Lancet, vol. 396, no. 10253, pp. 770-778 . https://doi.org/10.1016/S0140-6736(20)31788-8
Lancet (London, England)

Background\ud The anti-progesterone drug mifepristone and the prostaglandin misoprostol can be used to treat missed miscarriage. However, it is unclear whether a combination of mifepristone and misoprostol is more effective than administering misopro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::571a3fdd86a99d3578188825e8dc88a4
https://www.pure.ed.ac.uk/ws/files/171906498/1_s2.0_S0140673620317888_main.pdf

Dysmenorrhoea

Autor: Kate Stewart, Shilpa Deb

Publikováno v: Obstetrics, Gynaecology & Reproductive Medicine. 26:364-367

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bd98b9efa104eb2586a6e0b530f3cc1e
https://doi.org/10.1016/j.ogrm.2016.09.004